Private Advisor Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-7,562
| Closed | -$25K | – | 3935 |
|
|
2020
Q2 | $25K | Buy |
+7,562
| New | +$25K | ﹤0.01% | 2472 |
|
|
2017
Q3 | – | Sell |
-8,759
| Closed | -$99K | – | 1524 |
|
|
2017
Q2 | $99K | Sell |
8,759
-464
| -5% | -$5.24K | ﹤0.01% | 1332 |
|
|
2017
Q1 | $227K | Sell |
9,223
-75
| -0.8% | -$1.85K | 0.01% | 1213 |
|
|
2016
Q4 | $241K | Sell |
9,298
-2,370
| -20% | -$61.4K | 0.01% | 1055 |
|
|
2016
Q3 | $547K | Buy |
11,668
+909
| +8% | +$42.6K | 0.02% | 617 |
|
|
2016
Q2 | $483K | Sell |
10,759
-1,589
| -13% | -$71.3K | 0.02% | 642 |
|
|
2016
Q1 | $813K | Buy |
12,348
+1,786
| +17% | +$118K | 0.04% | 426 |
|
|
2015
Q4 | $657K | Buy |
10,562
+1,727
| +20% | +$107K | 0.03% | 514 |
|
|
2015
Q3 | $592K | Buy |
8,835
+416
| +5% | +$27.9K | 0.03% | 513 |
|
|
2015
Q2 | $819K | Buy |
8,419
+1,079
| +15% | +$105K | 0.04% | 435 |
|
|
2015
Q1 | $686K | Buy |
+7,340
| New | +$686K | 0.04% | 463 |
|